Q&A With Hendrik Nolte From Merck: Sublingual Allergy Therapy Provides Alternatives To Shots And Pills

Video

For patients with seasonal allergies the prescription medications available may not be enough to help with their symptoms and shots may not be an option they want to consider. Newly developed sublingual immunotherapies have been developed to help these patients manage their daily lives.

For patients with seasonal allergies the prescription medications available may not be enough to help with their symptoms and shots may not be an option they want to consider. Newly developed sublingual immunotherapies have been developed to help these patients manage their daily lives.

Hendrik Nolte, MD, PhD, who serves as the clinical leader for Merck's allergy immunotherapy program discussed how patients allergic to grass and other allergens are getting help now with more treatments on the horizon during the American College of Allergy Asthma & Immunology's annual meeting in San Antonion.

Related Videos
James Palmer, MD | Credit: Penn Medicine
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Robert Wood, MD | Credit: LinkedIn
Robert Wood, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.